期刊文献+

盐酸芬戈莫德对结肠癌小鼠肿瘤免疫相关因子的影响 被引量:2

Effects of fingolimod hydrochloride on TSGF in colon cancer mice
下载PDF
导出
摘要 目的通过盐酸芬戈莫德对CT26荷瘤小鼠肿瘤免疫相关因子功能的影响,探讨盐酸芬戈莫德的抗肿瘤作用机制。方法实验小鼠分为阴性对照组,盐酸芬戈莫德高、中、低剂量治疗组和荷瘤模型组,给药14d,分别检测以下指标:肿瘤生长抑制率、胸腺指数、脾脏指数、小鼠不同组织T细胞干扰素γ(IFN-γ)的分泌、效应T细胞(CD8^+CD3^+T细胞)的比例、不同组织调节性T细胞(CD4^+CD25^+Tregs)白细胞介素10(IL-10)的分泌。结果盐酸芬戈莫德明显升高CD8^+CD3^+T细胞在肿瘤局部的比例(P <0.05);盐酸芬戈莫德显著提高外周血和淋巴结中T细胞分泌IFN-γ的能力(P <0.05);盐酸芬戈莫德有抑制CD4^+CD25^+Tregs分泌IL-10的作用(P <0.05)。结论盐酸芬戈莫德可能通过影响Tregs的免疫抑制功能发挥抗肿瘤的作用。 Objective To investigate the antitumor mechanism of fingolimod hydrochloride through analysis of fingolimod hydrochloride on TSGF in colon cancer mice. Methods The mice were divided into negative control group,fentanyl hydrochloride high,medium and low dose treatment group and tumor-bearing model group,and were given for 14 days.The tumor growth inhibition rate,thymus index,spleen index,the secretion of IFN-γ,the proportion of effector T cells(CD8+CD3+T),and the secretion of interleukin 10(IL-10)by regulatory T cells(CD4+CD25+Tregs) were detected. Results Fingolimod hydrochloride was significantly increased the proportion of CD8+CD3+T cells in local tumor(P<0.05).Fingolimod hydrochloride increased the ability of T cells in peripheral blood and lymph nodes to secrete IFN-γ significantly(P<0.05).Fingolimod hydrochloride inhibited the secretion of IL-10 by CD4+CD25+Tregs(P<0.05). Conclusion Fingolimod hydrochloride may play an anti-tumor role by affecting the immunosuppressive function of Tregs.
作者 阮志燕 陈庆凤 赖满香 RUAN Zhiyan;CHEN Qingfeng;LAI Manxiang(College of Pharmacy,Guangdong Food and Drug Vocational College,Guangzhou 510520,China)
出处 《中国医药科学》 2019年第5期14-17,共4页 China Medicine And Pharmacy
基金 广东省医学科研基金立项项目(A2016046) 广东省中医药常规科研项目(20162031) 广东食品药品职业学院校级课题(2015YZ013)
关键词 盐酸芬戈莫德 CT26结肠癌 调节性T细胞 Γ干扰素 Fingolimod hydrochloride CT26 colon cancer Regulatory T cells IFN-γ
  • 相关文献

参考文献1

二级参考文献16

  • 1Ok S, Kim S M, Kim C, et al. Emodin inhibits invasion and migration of prostate and lung cancer cells by downregulating the expression of chemokine receptor CXCR4[J]. Immunopharmacol Immunotoxicol, 2012, 34 (5): 768.
  • 2Mailloux A W, Young M R. Regulatory T-cell trafficking: from thymic development to tumor-induced immune suppression [J].Crit Rev Immunol, 2010, 30 (5): 435.
  • 3Hoffman 1: A, Hansen W P. Immunofluorescent analysis of blood cells by flow cytometry [J]. Int J Immunopharmacol, 1981, 3 (3): 249.
  • 4Thornton A M, Shevaeh E M. Suppressor effector function of CD4+CD25+ immunoregulatory T ceils is antigen nonspeeific [J]. J Immunol, 2000, 164 (1): 183.
  • 5Fu J, Xu D, Liu Z, et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellulm" carcinoma patients[J]. Gastroenterology, 2007, 132 (7) : 2328.
  • 6Hiraoka N, Onozato K, Kosuge T, et al. Prevalence of FOXP3: regulatory T cells increases during the progression of pancreatic duetal adenocareinoma and its premaliguant lesions[J]. Clin CancerRes, 2006, 12 (18): 5423.
  • 7Wolf D, Wolf A M, Rumpold H, et al. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer [J]. Clin Cancer Res, 2005, 11 (23): 8326.
  • 8Steitz J, Bruck J, Lenz J, et al. Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8 (+) T-cell-dependent immune defense of BI6 melanoma[J]. Cancer Res, 2001, 61 (24): 8643.
  • 9Wang H Y, Peng G, Guo Z, et al. Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor ceils byantigen-specific CD4: regulatory T cells[J]. J Immunol, 2005, 174 (5): 2661.
  • 10Ormandy L A, Hillemann T, Wedemeyer H, et al. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma[J]. Cancer Res, 2005, 65 (6): 2457.

共引文献3

同被引文献29

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部